Comparative Effects of Pilates Breathing and Pursed Lip Breathing on Chest Expension and Peak Expiratory Flow Rate in Patients With Chronic Obstructive Lung Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-64
SponsorFoundation University Islamabad

About this trial

Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.

Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 40-64 years

Both genders (male and female)

Grade 1-3 on mMRC scale of dyspnea

COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted

Disqualifiers

Moderate, severe and very severe stage of COPD according to GOLD classification

Patients having acute exerbation of COPD

Patients diagnosed with acute infection

Patients unable to follow command and instructions

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pilates Breathing Technique along with standard pharmacological management

    Procedure/Surgery

    Patients in this group will receive pilates breathing technique along with pharmacological management. A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose. While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.

  • Pursed-lip breathing along with pharmacological management

    Procedure/Surgery

    Patient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home. The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist

Treatment groups

46 Participants
are divided into 2 treatment groups
Group A: Group AExperimental treatment 1 intervention
Group B: Group BExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Chest Expansion

Evaluation will be done using inch tape (inches) for Chest Expansion

Time frame
03 weeks
2

Peak expiratory flow rate

Evaluation will be done by using Peak flow meter

Time frame
03 weeks
3

Dyspnea

Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)

Time frame
03 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.